| IPG515 | 
                            
                                    Insertion of a balloon device to disimpact an engaged fetal head before an emergency caesarean section
                                
                             | 
                            
Interventional procedure guidance 
 | 
                                
                                            Intrapartum care
                                        
                                 | 
                        
                            | IPG517 | 
                            
                                    Insertion of endobronchial nitinol coils to improve lung function in emphysema
                                
                             | 
                            
Interventional procedure guidance 
 | 
                                
                                            Chronic obstructive pulmonary disease
                                        
                                 | 
                        
                            | QS84 | 
                            
                                    Physical activity: encouraging activity in all people in contact with the NHS
                                
                             | 
                            
Quality standards 
 | 
                                
                                            Physical activity
                                        
                                 | 
                        
                            | TA337 | 
                            
                                    Rifaximin for preventing episodes of overt hepatic encephalopathy
                                
                             | 
                            
Technology appraisal guidance 
 | 
                                
                                            Liver conditions: general and other
                                        
                                 | 
                        
                            | QS85 | 
                            
                                    Managing medicines in care homes
                                
                             | 
                            
Quality standards 
 | 
                                
                                            Medicines management: general and other
                                        
                                 | 
                        
                            | TA336 | 
                            
                                    Empagliflozin in combination therapy for treating type 2 diabetes
                                
                             | 
                            
Technology appraisal guidance 
 | 
                                
                                            Diabetes
                                        
                                 | 
                        
                            | QS82 | 
                            
                                    Smoking: reducing tobacco use
                                
                             | 
                            
Quality standards 
 | 
                                
                                            Smoking and tobacco
                                        
                                 | 
                        
                            | QS86 | 
                            
                                    Falls in older people: assessment after a fall and preventing further falls
                                
                             | 
                            
Quality standards 
 | 
                                
                                            Injuries, accidents and wounds: general and other
                                        
                                 | 
                        
                            | TA338 | 
                            
                                    Pomalidomide for relapsed and refractory multiple myeloma previously treated with lenalidomide and bortezomib
                                
                             | 
                            
Technology appraisal guidance 
 | 
                                
                                            Blood and bone marrow cancers
                                        
                                 | 
                        
                            | QS83 | 
                            
                                    Alcohol: preventing harmful alcohol use in the community
                                
                             | 
                            
Quality standards 
 | 
                                
                                            Communities
                                        
                                 | 
                        
                            | IPG514 | 
                            
                                    Transanal total mesorectal excision of the rectum
                                
                             | 
                            
Interventional procedure guidance 
 | 
                                
                                            Colorectal cancer
                                        
                                 | 
                        
                            | IPG516 | 
                            
                                    Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantation
                                
                             | 
                            
Interventional procedure guidance 
 | 
                                
                                            Cardiovascular conditions: general and other
                                        
                                 | 
                        
                            | IPG518 | 
                            
                                    Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetes
                                
                             | 
                            
Interventional procedure guidance 
 | 
                                
                                            Diabetes
                                        
                                 | 
                        
                            | MTG24 | 
                            
                                    The Sherlock 3CG Tip Confirmation System for placement of peripherally inserted central catheters
                                
                             | 
                            
Medical technology guidance 
 | 
                                
                                            Surgical care
                                        
                                 | 
                        
                            | TA335 | 
                            
                                    Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome
                                
                             | 
                            
Technology appraisal guidance 
 | 
                                
                                            Acute coronary syndromes
                                        
                                 | 
                        
                            | IPG512 | 
                            
                                    Implantation of a shock or load absorber for mild to moderate symptomatic medial knee osteoarthritis
                                
                             | 
                            
Interventional procedure guidance 
 | 
                                
                                            Knee conditions
                                        
                                 | 
                        
                            | NG7 | 
                            
                                    Maintaining a healthy weight and preventing excess weight gain among adults and children
                                
                             | 
                            
Guideline 
 | 
                                
                                            Diet, nutrition and obesity
                                        
                                 | 
                        
                            | NG6 | 
                            
                                    Excess winter deaths and morbidity and the health risks associated with cold homes
                                
                             | 
                            
Guideline 
 | 
                                
                                            Vulnerable groups
                                        
                                 | 
                        
                            | NG5 | 
                            
                                    Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes
                                
                             | 
                            
Guideline 
 | 
                                
                                            Medicines management: general and other
                                        
                                 | 
                        
                            | CG28 | 
                            
                                    Depression in children and young people: Identification and management in primary, community and secondary care
                                
                             | 
                            
Clinical guidelines 
 | 
                                
                                            Children and young people
                                         | 
 
No hay comentarios:
Publicar un comentario